February 21, 2024 · Form 4 insider transaction
Reich Kristian sold 569 shares of MOONLAKE THERAPEUTICS at $55.30 per share, a transaction worth $31.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 16, 2023.; The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.15 to $55.33. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.